In line with our Pharma Sustainability target of supporting activities that will help provide 100 million women in low-and lower-middle-income countries (LMICs) with modern contraception by 2030, Bayer has collaborated with The Challenge Initiative (TCI) at Johns Hopkins University, co-funded by the Bill and Melinda Gates Foundation, to launch an article series aimed at giving women a voice in telling her own family planning stories.
TCI is designed to create sustainable programs with strong local ownership and institutionalization within LMICs, to create a long-term impact which will provide several million women with freedom of choice when it comes to planning their families and futures. TCI has already supported over one million women in East and West Africa, India and the Philippines, and it continues to grow daily.
In our “Empowering Her, Health for All: The different Faces of Family Planning” story collection, we present you the journey of real-life women and girls. We hope you will continue to check in to learn more about how real women are impacted by their family planning journeys and decisions.
Watch the following video, to hear local women telling their family planning stories and explaining how it changed their lives.
Discover More
HEALTH FOR ALL
Empowering Women, Globally
By 2030, we are committed to providing 100 million women in low- and middle-income countries with access to modern contraception.
READ MORE
HEALTH FOR ALL
Fighting Neglected Tropical Diseases
Together with the World Health Organization (WHO) and other partners, we are improving public health in some of the most underserved regions of the world by working to eliminate the impact of the most devastating Neglected Tropical Diseases (NTDs) by 2030.
READ MORE
HEALTH FOR ALL
Strengthening Healthcare Access
In collaboration with our partners, we aim to support more patients in low- and middle-income countries (LMICs) to access our medicines, for a healthier global society.
READ MORE
HEALTH FOR ALL
Ensuring a Sustainable Product Supply
We are constantly seeking new ways to reduce the environmental impact of our own operations and lead sustainability efforts in the pharmaceutical industry, in line with our sustainability commitments.